Concinnity Genetics
Edinburgh
About Concinnity Genetics
Concinnity Genetics transforms the safety of gene therapies by designing novel control mechanisms using an AI platform.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $3.8M
- Funding stage: Seed
- Last round: Seed (Dec 2024)
- Website: concinnitygenetics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/concinnity-genetics-66637 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.